Influence of exercise on NA- and Hsp72-induced release of IFNγ by the peritoneal suspension of macrophages and lymphocytes from genetically obese Zucker rats.
Regular physical exercise is recognized as a nonpharmacological therapeutic strategy in the treatment of metabolic syndrome, and has been proposed for improving obesity, diabetic status, insulin resistance, and immune response. The aim of the present study was to evaluate the effect of a regular exercise program (treadmill running, 5 days/week for 14 weeks at 35 cm/s for 35 min in the last month) on the release of the pro-inflammatory cytokine interferon gamma (IFNγ) by peritoneal cells (macrophages and lymphocytes) from obese Zucker rats (fa/fa) in response to noradrenaline (NA) and heat shock proteins of 72 kDa (Hsp72), and the possible adaptation due to training for a bout acute exercise (a single session of 25-35 min at 35 cm/s). In healthy (lean Fa/fa) and obese animals, peritoneal cells released greater concentrations of IFNγ in response to Hsp72 and lower concentrations in response to NA. The regular exercise training protocol, evaluated in the obese animals, produced a clear change in the regulation of the release of IFNγ. Peritoneal immune cells from trained animals released more IFNγ in response to NA, but there was a reduction in the release of IFNγ in response to Hsp72. In the obese animals, regular exercise caused a change in the inhibitory effect of NA (which now becomes stimulatory) and the stimulatory effect of Hsp72e (which now becomes inhibitory) in relation to the release of IFNγ. This reflects that Hsp72, induced by the prior release of NA following exercise-induced stress, plays a role in the homeostatic balance of release of IFNγ by peritoneal immune cells in obese animals during exercise.
Immunophysiology Research Group, Department of Physiology, Faculty of Sciences, University of Extremadura, Badajoz, Spain.
L
L
Martín-Cordero
J J
JJ
García
M D
MD
Hinchado
E
E
Bote
E
E
Ortega
D000818:Animals; D050884:HSP72 Heat-Shock Proteins / Q000494:pharmacology*; D007371:Interferon-gamma / Q000096:biosynthesis / Q000378:metabolism*; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D008297:Male; D024821:Metabolic Syndrome / Q000276:immunology / Q000473:pathology*; D009638:Norepinephrine / Q000494:pharmacology*; D009765:Obesity / Q000276:immunology / Q000473:pathology*; D010805:Physical Conditioning, Animal; D061251:Primary Cell Culture; D051381:Rats; D011924:Rats, Zucker
D050884:HSP72 Heat-Shock Proteins; D007371:Interferon-gamma; D009638:Norepinephrine